Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-063101

SVP, Diagnostics, clonoSEQ sold 25,000 shares at $55.00 ($1,375,000)

  • SVP, Diagnostics, clonoSEQ acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ 2020-12-10 Option exercise +25,000 $1.98 $49,500 25,000 D
BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ 2020-12-10 Sale −25,000 $55.00 $1,375,000 0 D
Derivatives
BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ 2020-12-10 Option exercise · Stock Option (Right to Buy) −25,000 30,000 D
Open-market sales · 25,000 sh · avg $55.00 · $1,375,000
Loading xslF345X03/doc4.xml…